Oh yeah. Rocket ship today….
- Forums
- ASX - By Stock
- XF1
- Ann: Xref achieves 71% Sales Growth & $0.2m Cash Surplus Q2FY22
XF1
xref limited
Add to My Watchlist
3.23%
!
16.0¢

Ann: Xref achieves 71% Sales Growth & $0.2m Cash Surplus Q2FY22, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.0¢ |
Change
0.005(3.23%) |
Mkt cap ! $35.21M |
Open | High | Low | Value | Volume |
15.5¢ | 16.0¢ | 15.5¢ | $3.756K | 23.49K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20204 | 15.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 176936 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20204 | 0.155 |
1 | 12681 | 0.150 |
1 | 129429 | 0.135 |
3 | 96000 | 0.130 |
1 | 500000 | 0.125 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 176936 | 1 |
0.165 | 153136 | 4 |
0.170 | 242000 | 2 |
0.180 | 41059 | 1 |
0.230 | 47500 | 1 |
Last trade - 11.23am 01/07/2025 (20 minute delay) ? |
Featured News
XF1 (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online